Recurrent cyclin D2 mutations in myeloid neoplasms.

Khanna, V; Eide, C A; Tognon, C E; Maxson, J E; Wilmot, B; Bottomly, D; McWeeney, S; Edwards V, D K; Druker, B J; Tyner, J W

Khanna, V; Eide, C A; Tognon, C E; Maxson, J E; Wilmot, B; Bottomly, D; McWeeney, S; Edwards V, D K; Druker, B J; Tyner, J W.

Afiliación

Khanna V; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Eide CA; Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute, Portland, OR, USA.
Tognon CE; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Maxson JE; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Wilmot B; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.
Bottomly D; Howard Hughes Medical Institute, Portland, OR, USA.
McWeeney S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Edwards V DK; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.
Druker BJ; Howard Hughes Medical Institute, Portland, OR, USA.
Tyner JW; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.

Leukemia ; 31(9): 2005-2008, 2017 09.

Article en En | MEDLINE | ID: mdl-28630439

Asunto(s)

Ciclina D2/genética; Mutación; Trastornos Mieloproliferativos/genética; Animales; Humanos; Ratones; Células 3T3 NIH

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ciclina D2 / Mutación / Trastornos Mieloproliferativos Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google